Global Biochips Market 2024-2028
Global Biochips Market 2024-2028
The biochips market is forecasted to grow by USD 72273.7 mn during 2023-2028, accelerating at a CAGR of 30.73% during the forecast period. The report on the biochips market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing applications of microarray biochips in drug discovery, increase in market presence of market players with collaboration strategy, and growing use of personalized medicines.
Technavio's biochips market is segmented as below:
- By End-user
- Biotechnology and pharmaceutical companies
- Hospitals and diagnostics centers
- Academic and research institutes
- By Technology
- Microarrays
- Microfluidics
- By Geographical Landscape
- North America
- Europe
- APAC
- Middle East and Africa
- South America
This study identifies the increasing use of chemical microarray technology as one of the prime reasons driving the biochips market growth during the next few years. Also, emerging loc technology and growth in the bioinformatics software industry will lead to sizable demand in the market.
The report on the biochips market covers the following areas:
- Biochips market sizing
- Biochips market forecast
- Biochips market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biochips market vendors that include Agilent Technologies Inc., Analis sa, Arrayit Corp., BICO Group AB, Bio Rad Laboratories Inc., Boao Bio Group Co. Ltd., Dynamic Biosensors GmbH, Eden Tech, Greiner Bio One International GmbH, IDEX Corp., Illumina Inc., INNOPSYS, Micronit BV, Nutcracker Therapeutics Inc., Perkin Elmer Inc., QIAGEN NV, Randox Laboratories Ltd., Sphere Fluidics Ltd., Takara Holdings Inc., and Thermo Fisher Scientific Inc.. Also, the biochips market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.